SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039007
Filing Date
2023-05-12
Accepted
2023-05-12 16:06:09
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_chinapharma.htm   iXBRL 10-Q 508225
2 CERTIFICATION f10q0323ex31-1_chinapharma.htm EX-31.1 13693
3 CERTIFICATION f10q0323ex31-2_chinapharma.htm EX-31.2 13935
4 CERTIFICATION f10q0323ex32-1_chinapharma.htm EX-32.1 8012
  Complete submission text file 0001213900-23-039007.txt   3648486

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20230331.xsd EX-101.SCH 49852
6 XBRL CALCULATION FILE cphi-20230331_cal.xml EX-101.CAL 36343
7 XBRL DEFINITION FILE cphi-20230331_def.xml EX-101.DEF 193282
8 XBRL LABEL FILE cphi-20230331_lab.xml EX-101.LAB 383123
9 XBRL PRESENTATION FILE cphi-20230331_pre.xml EX-101.PRE 204077
58 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_chinapharma_htm.xml XML 315050
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 23915630
SIC: 2834 Pharmaceutical Preparations